Makedonsko Farmacevtski Bilten (Jan 2015)

Involvement of serum HSP 70 in Guillain-Barré Syndrome: An exploratory study and a review of current literature

  • Aida Loshaj-Shala,
  • Ana Poceva Panovska,
  • Katerina Brezovska,
  • Giangiacomo Beretta,
  • Ljubica Suturkova,
  • Slobodan Apostolski

Journal volume & issue
Vol. 61, no. (1)
pp. 61 – 67

Abstract

Read online

The evolutionary conserved family of heat shock proteins (HSP) is responsible for protecting cells against different types of stress. Although the levels of HSP can be readily measured in serum, the levels of HSP 70 in patients Guillain-Barre Syndrome (GBS) have not been studied before. To this aim we investigate whether patients with GBS (n=21) had altered serum HSP 70 levels compared to healthy controls (HC, n=9) and to patients affected by other immune disorders such as multifocal motor neuropathy (MMN, n=4) and chronic inflammatory demyelinating polyneuropathy (CIDP, n=6). The highest HSP 70 value (15.78 ± 1.72 ng/mL) was found in one patient in the GBS group, although we have found that serum HSP70 levels were significantly higher in 2 out of the 21 GBS patients (9.5%). Hence, it is of interest to underline that the patient with the highest HSP70 level, had also the best recovery rate. Моrе extensive research is required in order to support the hypothesis that HSP 70 serum concentration may be a useful biomarker for the prediction of remission outcome for GBS patients.